A new research has identified that 'megakaryocytes' or 'megacells' are responsible for playing a critical role in adult stem cell transplant.
Hematopoietic stem cells differentiate to generate megakaryocytes in bone marrow and the study has shown that the hematopoietic stem cells (the parent cells) could be directly controlled by their own progeny (megakaryocytes).
The results had suggested that megakaryocytes might be used clinically to facilitate adult stem cell regeneration and to expand cultured cells for adult stem cell transplants.
Researchers at Stowers Institute for Medical Research had discovered that megakaryocytes had directly regulated the function of murine hematopoietic stem cells-adult stem cells that had formed the blood and immune cells and that had constantly renewed the body's blood supply. These cells could also develop into all types of blood cells, including white blood cells, red blood cells, and platelets.
Because of their remarkable ability to renew themselves and differentiate into other cells, hematopoietic stems cells have been used to treat many diseases and conditions. The transplantation of isolated human hematopoietic stem cells has been used in the treatment of anemia, immune deficiencies and other diseases, including cancer.
The study was published in the journal Nature Medicine.